Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

April Armstrong; Melinda Gooderham; Kilian Eyerich; Kristian Reich; Andrew Blauvelt; H. Chih-ho Hong; Roger A. Edwards; Gianluca Bonfanti; Claire Clibborn; Pinaki Biswas; Gary Chan; Claire Feeney; Erman Güler

doi:10.17632/gcf3f9mwnc

Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

Mendeley Data 2026 Dataset Open access

Read full text

Authors: April Armstrong, Melinda Gooderham, Kilian Eyerich, Kristian Reich, Andrew Blauvelt, H. Chih-ho Hong, Roger A. Edwards, Gianluca Bonfanti, Claire Clibborn, Pinaki Biswas, Gary Chan, Claire Feeney

+1 more

Erman Güler

DOI: 10.17632/gcf3f9mwnc

Cited by: 0

Fields of Study & Subjects

Dermatology and Skin Diseases Asthma and respiratory diseases Psoriasis: Treatment and Pathogenesis

Publication details

Journal / source: Mendeley Data
Publication date: 15 January 2026
Document type: Dataset